Abingworth LLP
- SEC CIK
- 0001397144
Holdings, Q4 2022
Positions as of Dec 31, 2022, filed Feb 10, 2023.SEC
- Positions
- 19
- 0 vs. Q3 2022
- Total value
- $306.92M
- +$14.44M (+4.9%) vs. Q3 2022
Compare with Q3 2022: new, added, reduced and sold out
Positions
Long positions only. Changes compare share counts with Q3 2022.
| Security | Class | Shares | Value | % of portfolio | Change in shares | Action | History |
|---|---|---|---|---|---|---|---|
| PCVXVAXCYTE INC | COM | 2,019,057 | $96.81M | 31.54% | −2,149,661−51.6% | Reduced | View |
| VERONA PHARMA PLC925050106 | SPONSORED ADS | 2,457,500 | $64.21M | 20.92% | 00.0% | Unchanged | – |
| VERAVERA THERAPEUTICS INC | CL A | 2,960,231 | $57.28M | 18.66% | 00.0% | Unchanged | View |
| HILLEVAX INC43157M102 | COM | 1,838,486 | $30.76M | 10.02% | 00.0% | Unchanged | – |
| ACETADICET BIO INC | COM | 2,115,385 | $18.91M | 6.16% | 00.0% | Unchanged | View |
| PHATPHATHOM PHARMACEUTICALS INC | COM | 1,435,106 | $16.1M | 5.25% | 00.0% | Unchanged | View |
| RENEO PHARMACEUTICALS INC75974E103 | COM | 2,073,957 | $4.83M | 1.57% | 00.0% | Unchanged | – |
| SIENTRA INC82621J105 | COM | 1,673,589 | $3.4M | 1.11% | 00.0% | Unchanged | – |
| JSPRJASPER THERAPEUTICS INC | COM | 5,628,558 | $2.72M | 0.89% | 00.0% | Unchanged | View |
| SOLENO THERAPEUTICS INC834203309 | COM | 1,201,506 | $2.38M | 0.78% | 00.0% | Unchanged | – |
| NCNANUCANA PLC | SPONSORED ADR | 3,333,333 | $2.2M | 0.72% | 00.0% | Unchanged | View |
| EFFECTOR THERAPEUTICS INC28202V108 | COM | 4,822,114 | $2.06M | 0.67% | 00.0% | Unchanged | – |
| SPRBSPRUCE BIOSCIENCES INC | COM | 1,792,518 | $1.97M | 0.64% | 00.0% | Unchanged | View |
| PARATEK PHARMACEUTICALS INC699374302 | COM | 1,041,131 | $1.95M | 0.63% | 00.0% | Unchanged | – |
| CYMABAY THERAPEUTICS INC23257D103 | COM | 131,036 | $821.6K | 0.27% | 00.0% | Unchanged | – |
| XCUREXICURE INC | COM NEW | 281,636 | $323.88K | 0.11% | 00.0% | Unchanged | View |
| AEGLEA BIOTHERAPEUTICS INC00773J103 | COM | 240,500 | $108.23K | 0.04% | 00.0% | Unchanged | – |
| MOLECULAR TEMPLATES INC608550109 | COM | 200,000 | $66K | 0.02% | 00.0% | Unchanged | – |
| OBSEVA SAH5861P103 | COM | 87,999 | $12.76K | 0.00% | 00.0% | Unchanged | – |
13F filings by quarter
| Quarter | Filed | Positions | Total value | Changes | Filing |
|---|---|---|---|---|---|
| Q4 2022 | Feb 10, 2023 | 19 | $306.92M | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 10, 2022 | 19 | $292.48M | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 15, 2022 | 21 | $312.4M | vs. Q1 2022 | SEC |
| Q1 2022 | May 16, 2022 | 20 | $352.5M | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 16, 2022 | 20 | $412.7M | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 15, 2021 | 20 | $440.67M | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 16, 2021 | 19 | $323.5M | vs. Q1 2021 | SEC |
| Q1 2021 | May 17, 2021 | 17 | $289.55M | – | SEC |